| abstract |
The invention relates to a pharmaceutical composition containing ibrutinib. The active component of the composition is the ibrutinib. The composition is characterized in that medium- and long-chain saturated or unsaturated aliphatic acids, substituted carboxylic acids, and the like, which are pharmaceutical acids or a mixture of one or more acids therein or fish oil are adopted as lipophilic components, proper water is added to prepare a hydrophilic substrate or not added according to different requirements of each dosage form, and the composition is suitable for preparation of soft capsules, ointment, eye drops, oral liquids, injections, and other dosage forms. |